4.4 Review

Reducing rates of chronic breast cancer-related lymphedema with screening and early intervention: an update of recent data

Related references

Note: Only part of the references are listed.
Article Oncology

Prophylactic Use of Compression Sleeves Reduces the Incidence of Arm Swelling in Women at High Risk of Breast Cancer-Related Lymphedema: A Randomized Controlled Trial

Vincent S. Paramanandam et al.

Summary: The study found that prophylactic use of compression sleeves could reduce and delay the occurrence of arm swelling in women at high risk for lymphedema in the first year after surgery for breast cancer.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Review Oncology

Prospective Surveillance for Breast Cancer-Related Arm Lymphedema: A Systematic Review and Meta-Analysis

Bolette S. Rafn et al.

Summary: The study found that participation in prospective surveillance with early management can reduce the risk of chronic lymphedema in breast cancer patients. Only a small number of patients who are at high risk of lymphedema due to axillary surgery develop chronic lymphedema. More research is needed to determine whether prospective surveillance with early management can reduce the risk of chronic lymphedema, especially for cancer survivors other than breast cancer.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Medicine, Research & Experimental

A Comparison of Bioimpedance Spectroscopy or Tape Measure Triggered Compression Intervention in Chronic Breast Cancer Lymphedema Prevention

Sheila H. Ridner et al.

Summary: This study found that compared to tape measurement, bioimpedance spectroscopy provides a more precise identification of patients likely to benefit from an early compression intervention.

LYMPHATIC RESEARCH AND BIOLOGY (2022)

Article Oncology

Prospective surveillance model in the home for breast cancer-related lymphoedema: a feasibility study

Louise A. Koelmeyer et al.

Summary: The study found that the prospective surveillance model in the home with BIS is feasible and leads to increased self-management. A Phase II randomized trial is needed, as well as research into the costs of implementing this model of care for high-risk individuals.

BREAST CANCER RESEARCH AND TREATMENT (2021)

Article Oncology

Implementing a prospective surveillance and early intervention model of care for breast cancer-related lymphedema into clinical practice: application of the RE-AIM framework

Louise Koelmeyer et al.

Summary: Chronic lymphedema following breast cancer can have significant impacts on individuals physically, functionally, psychologically, and financially. A study using the RE-AIM framework retrospectively showed that a prospective surveillance and early intervention model of care was effective in reducing progression rates to clinical lymphedema and was adopted by all hospital sites initially approached.

SUPPORTIVE CARE IN CANCER (2021)

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Review Oncology

BREAST CANCER-RELATED ARM LYMPHEDEMA: INCIDENCE RATES, DIAGNOSTIC TECHNIQUES, OPTIMAL MANAGEMENT AND RISK REDUCTION STRATEGIES

Chirag Shah et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)

Article Rehabilitation

Reliability study of measurements for lymphedema in breast cancer patients

Yu-Wei Chen et al.

AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2008)